Evidence map›Paper›PMID 20886194›Full record

ArticleThrombosis and haemostasis2011

Cysteine residues in CUB-1 domain are critical for ADAMTS13 secretion and stability.

Zhou Zhou, Hui-Chun Yeh, Hua Jing, Christina Wang, Zhenyin Tao, Huiwan Choi, Khatira Aboulfatova, Renhai Li, Jing-Fei Dong

Abstract read
In one paragraph

Article in Thrombosis and haemostasis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in immunology · 2019
    Article
  6. ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zhou ZhouSection of Cardiovascular Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Hui-Chun Yeh
Hua Jing
Christina Wang
Zhenyin Tao
Huiwan Choi
Khatira Aboulfatova
Renhai Li
Jing-Fei Dong
Baylor College of Medicine · USThe University of Texas Health Science Center at Houston · USTianjin Medical University · CN

Funding

Structure and Function of Platelet Glycoprotein lb-IX-V ComplexR01HL082808 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, RENHAO · 2006 to 2023
$6.4M
Ultra-Large VWF and Thrombotic MicroangiopathyR01HL071895 · NHLBI · BLOODWORKS · PI DONG, JING-FEI · 2003 to 2012
$3.4M
Proteolysis of ultralarge von Willebrand factor and metabolic syndrome-diabetesR01HL085769 · NHLBI · BLOODWORKS · PI DONG, JING-FEI · 2008 to 2011
$1.5M
NHLBI NIH HHS HL71895NHLBI NIH HHS HL82808NHLBI NIH HHS R01 HL071895NHLBI NIH HHS R01 HL082808NHLBI NIH HHS R01 HL085769
6 · The paper itself

Abstract

Upon stimulation, endothelial cells release von Willebrand factor (VWF) enriched in ultra-large (UL) forms that are rapidly cleaved by ADAMTS13. The zinc metalloprotease fits in the consensus for members of the ADAMTS family, but also contains two unique C-terminal CUB domains. There are five and two cysteine residues in the CUB-1 and CUB-2 domains, respectively, instead of four as deducted from the consensus. In this study, we investigated the role of cysteine residues in the CUB-1 domain in ADAMTS13 synthesis and activity. CUB-1 and cysteine mutations were expressed in mammalian cell lines and examined for synthesis, secretion, stability, and VWF-cleaving activity. When expressed as an isolated domain, CUB-1, but not CUB-2, covalently aggregated. Converting any of the four cysteines that fit in the CUB consensus (C1192, C1213, C1236 and C1254) reduced the secretion of the mutants to the conditioned medium, but not to extracellular matrix. The mutations also resulted in a moderate increase in proteolytic degradation and decrease in cleaving VWF under static, but not flowing conditions. In contrast, replacing C1275, which was found to be in the thiol form, with a serine residue prevented covalent aggregation of CUB-1, but had no effect on secretion and VWF-cleaving activity. C1275S was also markedly resistant to proteolytic degradation. The data illustrate the importance of consensus cysteines in the secretion and proteolytic activity of ADAMTS13. They also identify an ADAMTS-13 mutant that is resistant to proteolytic degradation, while maintaining a normal VWF-cleaving activity.

Indexed as

ADAM ProteinsADAMTS13 ProteinAnimalsCell LineCysteineHumansMutagenesis, Site-DirectedMutant ProteinsPeptide HydrolasesProtein StabilityProtein Structure, Tertiaryvon Willebrand FactorADAM ProteinsADAMTS13 ProteinADAMTS13 protein, humanCysteineMutant ProteinsPeptide Hydrolasesvon Willebrand Factor

Identifiers

PMID20886194
PMCPMC5649353
OpenAlexW2165023063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.